Representative Byron Donalds (R-FL) spearheaded a bipartisan bill to ease regulations on small and family-owned domestic cigar producers. Aptly named the Cut ...

FoodNavigator-USA’s Healthy Alternatives session explores how food policy and consumer trends are shaping brands’ strategies ...

Thiruvananthapuram: In response to the escalating drug-related violence among youth, the state govt has directed the excise ...

WASHINGTON (7News) — The FDA may soon have a new leader. Dr. Marty Makary is a renowned Johns Hopkins surgeon and President Donald Trump's pick to head the Food and Drug Administration (FDA).

For example, two pharmaceutical companies may combine their research and development (R&D) teams by creating a syndicate to develop a new drug. Or several real estate companies may form a ...

On Monday, NBC reported the administration was reinstating some staff at the FDA’s medical-devices unit. "US delays decision on “healthy” definition" was originally created and published by Just Food, ...

You can get in touch with Marni by emailing [email protected]. According to the FDA, a Class I classification represents "a situation in which there is a reasonable probability that the use of ...

A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for this fall’s flu season has been canceled, a member of the advisory ...

WASHINGTON — Eli Lilly plans to spend $27 billion to build four new drug manufacturing sites in the United States, the company announced Wednesday, at a time when the Trump administration is ...

AI respresentative image U.S. health agencies will delay by more than two months a decision on updating the definition ... employees at the Food and Drug Administration and the National Institutes ...

WASHINGTON — Health agencies will delay by more than two months a decision on updating the definition of ... employees at the Food and Drug Administration and the National Institutes of Health ...

Drug compounders are taking legal action against the U.S. Food and Drug Administration, contesting the agency's recent decision to exclude Novo Nordisk's Wegovy and Ozempic from its drug shortage list ...